B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

WH Fridman, M Meylan, F Petitprez, CM Sun… - Nature reviews Clinical …, 2022 - nature.com
B cells are a major component of the tumour microenvironment, where they are
predominantly associated with tertiary lymphoid structures (TLS). In germinal centres within …

Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer

MCA Wouters, BH Nelson - Clinical Cancer Research, 2018 - AACR
There is abundant evidence that tumor-infiltrating CD8+ T cells contribute positively to
antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …

Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer

S Wang, W Liu, D Ly, H Xu, L Qu, L Zhang - Cellular & molecular …, 2019 - nature.com
Evidence indicates that lung cancer development is a complex process that involves
interactions between tumor cells, stromal fibroblasts, and immune cells. Tumor-infiltrating …

Clinical relevance of host immunity in breast cancer: from TILs to the clinic

P Savas, R Salgado, C Denkert, C Sotiriou… - Nature reviews Clinical …, 2016 - nature.com
The clinical relevance of the host immune system in breast cancer has long been
unexplored. Studies developed over the past decade have highlighted the biological …

[HTML][HTML] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

R Salgado, C Denkert, S Demaria, N Sirtaine… - Annals of oncology, 2015 - Elsevier
Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2–positive and triple …

C Denkert, G Von Minckwitz, JC Brase… - Journal of clinical …, 2015 - ascopubs.org
Purpose Modulation of immunologic interactions in cancer tissue is a promising therapeutic
strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 …

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype …

S Olbrecht, P Busschaert, J Qian, A Vanderstichele… - Genome Medicine, 2021 - Springer
Background High-grade serous tubo-ovarian cancer (HGSTOC) is characterised by
extensive inter-and intratumour heterogeneity, resulting in persistent therapeutic resistance …

Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer

DR Kroeger, K Milne, BH Nelson - Clinical Cancer Research, 2016 - AACR
Abstract Purpose: CD8+ tumor-infiltrating lymphocytes (TIL) are key mediators of antitumor
immunity and are strongly associated with survival in virtually all solid tumors. However, the …

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

L Zitvogel, L Galluzzi, MJ Smyth, G Kroemer - Immunity, 2013 - cell.com
Conventional chemotherapeutics and targeted antineoplastic agents have been developed
based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

C Denkert, S Wienert, A Poterie, S Loibl, J Budczies… - Modern …, 2016 - nature.com
Multiple independent studies have shown that tumor-infiltrating lymphocytes (TIL) are
prognostic in breast cancer with potential relevance for response to immune-checkpoint …